Referee report. For: Improving the predictive power of xenograft and syngeneic anti-tumour studies using mice humanised for pathways of drug metabolism [version 2; peer review: 1 approved, 1 approved with reservations] (2023)
Attributed to:
Developing new paradigms for overcoming drug resistance in cancer using novel humanised mouse models
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5256/f1000research.145248.r167840
Publication URI: https://f1000research.com/articles/11-1081/v2#referee-response-167840
Type: Other